The Latin America, Middle East and Africa Narcolepsy Therapeutics Market would witness market growth of 16.5% CAGR during the forecast period (2022-2028).
The neurotransmitter hypocretins control the sleep-wake cycle as well as other metabolic processes. Researchers have found that people with cataplexy and narcolepsy have lost hypocretin-producing cells in the brain's hypothalamus. Although it is an auto-immune illness, the reason why hypocretin cells are destroyed is not yet understood. The third most frequent sleep disorder identified narcolepsy affects a significant portion of the population.
Although narcolepsy cannot be cured, it can be managed with medications like methylphenidate, dextroamphetamine, and others to lessen the frequency of sleep attacks. In narcolepsy, the common tetrad of hypnagogic hallucinations, sleep paralysis, and cataplexy (a sudden loss of muscular tone on both sides) occur in combination with severe daytime fatigue and uncontrollable sleep episodes. Cataplexy, which is the term for bouts of rapid loss of muscle strength that affect about 70% of people, can be triggered by intense emotions.
The medical students and healthcare providers have reportedly been found to frequently have poor sleep quality. Increased rates of burnout and depression have been linked to sleep disruption. Performance and functionality have suffered as a result of this. In the United Arab Emirates, there is little research on this subject (UAE). In this study, medical and dental students in Dubai, United Arab Emirates, will have their sleep habits and mental states examined.
The Brazil market dominated the LAMEA Narcolepsy Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $118.4 million by 2028.The Argentina market is experiencing a CAGR of 17.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 16.2% during (2022 - 2028).
Based on Type, the market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy and Secondary Narcolepsy. Based on Product, the market is segmented into Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Narcolepsy Therapeutics Market is Predict to reach $5 Billion by 2028, at a CAGR of 10.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Jazz Pharmaceuticals plc, Shionogi & Co., Ltd., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc. (Arena Pharmaceuticals, Inc.), Bioprojet, Takeda Pharmaceutical Company Limited, Ligand Pharmaceuticals, Inc., and Graymark Healthcare, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Narcolepsy with Cataplexy
- Narcolepsy Without Cataplexy
- Secondary Narcolepsy
By Product
- Sodium Oxybate
- Selective Serotonin Reuptake Inhibitor
- Central Nervous System Stimulants
- Tricyclic Antidepressants
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Jazz Pharmaceuticals plc
- Shionogi & Co., Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
- Bioprojet
- Takeda Pharmaceutical Company Limited
- Ligand Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Narcolepsy Therapeutics Market, by Type
1.4.2 LAMEA Narcolepsy Therapeutics Market, by Product
1.4.3 LAMEA Narcolepsy Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Narcolepsy Therapeutics Market by Type
3.1 LAMEA Narcolepsy with Cataplexy Market by Country
3.2 LAMEA Narcolepsy Without Cataplexy Market by Country
3.3 LAMEA Secondary Narcolepsy Market by Country
Chapter 4. LAMEA Narcolepsy Therapeutics Market by Product
4.1 LAMEA Sodium Oxybate Market by Country
4.2 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country
4.3 LAMEA Central Nervous System Stimulants Market by Country
4.4 LAMEA Tricyclic Antidepressants Market by Country
4.5 LAMEA Others Market by Country
Chapter 5. LAMEA Narcolepsy Therapeutics Market by Country
5.1 Brazil Narcolepsy Therapeutics Market
5.1.1 Brazil Narcolepsy Therapeutics Market by Type
5.1.2 Brazil Narcolepsy Therapeutics Market by Product
5.2 Argentina Narcolepsy Therapeutics Market
5.2.1 Argentina Narcolepsy Therapeutics Market by Type
5.2.2 Argentina Narcolepsy Therapeutics Market by Product
5.3 UAE Narcolepsy Therapeutics Market
5.3.1 UAE Narcolepsy Therapeutics Market by Type
5.3.2 UAE Narcolepsy Therapeutics Market by Product
5.4 Saudi Arabia Narcolepsy Therapeutics Market
5.4.1 Saudi Arabia Narcolepsy Therapeutics Market by Type
5.4.2 Saudi Arabia Narcolepsy Therapeutics Market by Product
5.5 South Africa Narcolepsy Therapeutics Market
5.5.1 South Africa Narcolepsy Therapeutics Market by Type
5.5.2 South Africa Narcolepsy Therapeutics Market by Product
5.6 Nigeria Narcolepsy Therapeutics Market
5.6.1 Nigeria Narcolepsy Therapeutics Market by Type
5.6.2 Nigeria Narcolepsy Therapeutics Market by Product
5.7 Rest of LAMEA Narcolepsy Therapeutics Market
5.7.1 Rest of LAMEA Narcolepsy Therapeutics Market by Type
5.7.2 Rest of LAMEA Narcolepsy Therapeutics Market by Product
Chapter 6. Company Profiles
6.1 Jazz Pharmaceuticals plc
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Approvals and Trials:
6.2 Shionogi & Co., Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Research & Development Expenses
6.3 Teva Pharmaceutical Industries Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.4 Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional & Segmental Analysis
6.4.4 Research & Development Expense
6.5 Bioprojet
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 Takeda Pharmaceutical Company Limited
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Ligand Pharmaceuticals, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Graymark Healthcare, Inc.
6.8.1 Company Overview
TABLE 1 LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 12 LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 13 LAMEA Sodium Oxybate Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Sodium Oxybate Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 25 Brazil Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 26 Brazil Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 27 Brazil Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 28 Brazil Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 29 Brazil Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 30 Brazil Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 31 Argentina Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 32 Argentina Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 33 Argentina Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 34 Argentina Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 35 Argentina Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 36 Argentina Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 37 UAE Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 38 UAE Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 39 UAE Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 40 UAE Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 41 UAE Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 42 UAE Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 43 Saudi Arabia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 44 Saudi Arabia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 45 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 46 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 47 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 48 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 49 South Africa Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 50 South Africa Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 51 South Africa Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 52 South Africa Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 53 South Africa Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 54 South Africa Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 55 Nigeria Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 56 Nigeria Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 57 Nigeria Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 58 Nigeria Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 59 Nigeria Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 60 Nigeria Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 61 Rest of LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 62 Rest of LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 63 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 64 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 65 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 66 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 67 Key Information – Jazz Pharmaceuticals plc
TABLE 68 Key Information – Shionogi & Co., Ltd.
TABLE 69 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 70 Key Information – Pfizer, Inc.
TABLE 71 Key Information – Bioprojet
TABLE 72 Key Information – Takeda Pharmaceutical Company Limited
TABLE 73 Key Information – Ligand Pharmaceuticals, Inc.
TABLE 74 Key Information – Graymark Healthcare, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Jazz Pharmaceuticals PLC